202 related articles for article (PubMed ID: 29417765)
21. Inhibition of c-Jun N-terminal kinase sensitizes tumor cells to flavonoid-induced apoptosis through down-regulation of JunD.
Kook SH; Son YO; Jang YS; Lee KY; Lee SA; Kim BS; Lee HJ; Lee JC
Toxicol Appl Pharmacol; 2008 Mar; 227(3):468-76. PubMed ID: 18078968
[TBL] [Abstract][Full Text] [Related]
22. Distinct functions of JNK and c-Jun in oxidant-induced hepatocyte death.
Amir M; Liu K; Zhao E; Czaja MJ
J Cell Biochem; 2012 Oct; 113(10):3254-65. PubMed ID: 22644775
[TBL] [Abstract][Full Text] [Related]
23. Glaucocalyxin A activates FasL and induces apoptosis through activation of the JNK pathway in human breast cancer cells.
Li M; Jiang XG; Gu ZL; Zhang ZB
Asian Pac J Cancer Prev; 2013; 14(10):5805-10. PubMed ID: 24289581
[TBL] [Abstract][Full Text] [Related]
24. Targeting MUC1 and JNK by RNA interference and inhibitor inhibit the development of hepatocellular carcinoma.
Wang J; Ni WH; Hu KB; Zhai XY; Xie F; Jie J; Zhang NN; Jiang LN; Yuan HY; Tai GX
Cancer Sci; 2017 Mar; 108(3):504-511. PubMed ID: 28012230
[TBL] [Abstract][Full Text] [Related]
25. Upregulation of RhoB via c-Jun N-terminal kinase signaling induces apoptosis of the human gastric carcinoma NUGC-3 cells treated with NSC12618.
Kim BK; Kim HM; Chung KS; Kim DM; Park SK; Song A; Won KJ; Lee K; Oh YK; Lee K; Song KB; Simon JA; Han G; Won M
Carcinogenesis; 2011 Mar; 32(3):254-61. PubMed ID: 21084431
[TBL] [Abstract][Full Text] [Related]
26. Cerebral ischemia provokes a profound exchange of activated JNK isoforms in brain mitochondria.
Zhao Y; Herdegen T
Mol Cell Neurosci; 2009 Jun; 41(2):186-95. PubMed ID: 19289169
[TBL] [Abstract][Full Text] [Related]
27. Cordycepin causes p21WAF1-mediated G2/M cell-cycle arrest by regulating c-Jun N-terminal kinase activation in human bladder cancer cells.
Lee SJ; Kim SK; Choi WS; Kim WJ; Moon SK
Arch Biochem Biophys; 2009 Oct; 490(2):103-9. PubMed ID: 19733546
[TBL] [Abstract][Full Text] [Related]
28. Involvement of stress activated protein kinases (JNK and p38) in 1,25 dihydroxyvitamin D3-induced breast cell death.
Brosseau CM; Pirianov G; Colston KW
Steroids; 2010 Dec; 75(13-14):1082-8. PubMed ID: 20654640
[TBL] [Abstract][Full Text] [Related]
29. Mixed lineage kinase-3/JNK1 axis promotes migration of human gastric cancer cells following gastrin stimulation.
Mishra P; Senthivinayagam S; Rangasamy V; Sondarva G; Rana B
Mol Endocrinol; 2010 Mar; 24(3):598-607. PubMed ID: 20150185
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of the JNK signaling pathway increases sensitivity of hepatocellular carcinoma cells to cisplatin by down-regulating expression of P-glycoprotein.
Liu XY; Liu SP; Jiang J; Zhang X; Zhang T
Eur Rev Med Pharmacol Sci; 2016; 20(6):1098-108. PubMed ID: 27049263
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of tumor growth, angiogenesis, and tumor cell proliferation by a small molecule inhibitor of c-Jun N-terminal kinase.
Ennis BW; Fultz KE; Smith KA; Westwick JK; Zhu D; Boluro-Ajayi M; Bilter GK; Stein B
J Pharmacol Exp Ther; 2005 Apr; 313(1):325-32. PubMed ID: 15626722
[TBL] [Abstract][Full Text] [Related]
32. Juglanin induces apoptosis and autophagy in human breast cancer progression via ROS/JNK promotion.
Sun ZL; Dong JL; Wu J
Biomed Pharmacother; 2017 Jan; 85():303-312. PubMed ID: 27899257
[TBL] [Abstract][Full Text] [Related]
33. c-Jun N-terminal kinase has a pivotal role in the maintenance of self-renewal and tumorigenicity in glioma stem-like cells.
Yoon CH; Kim MJ; Kim RK; Lim EJ; Choi KS; An S; Hwang SG; Kang SG; Suh Y; Park MJ; Lee SJ
Oncogene; 2012 Nov; 31(44):4655-66. PubMed ID: 22249269
[TBL] [Abstract][Full Text] [Related]
34. Endogenous c-Jun N-terminal kinase (JNK) activity marks the boundary between normal and malignant granulosa cells.
Bildik G; Akin N; Senbabaoglu F; Esmalian Y; Sahin GN; Urman D; Karahuseyinoglu S; Ince U; Palaoglu E; Taskiran C; Arvas M; Guzel Y; Yakin K; Oktem O
Cell Death Dis; 2018 Apr; 9(4):421. PubMed ID: 29549247
[TBL] [Abstract][Full Text] [Related]
35. SP600125 inhibits cap-dependent translation independently of the c-Jun N-terminal kinase pathway.
Ito M; Kitamura H; Kikuguchi C; Hase K; Ohno H; Ohara O
Cell Struct Funct; 2011; 36(1):27-33. PubMed ID: 21263197
[TBL] [Abstract][Full Text] [Related]
36. Synergetic and Antagonistic Molecular Effects Mediated by the Feedback Loop of p53 and JNK between Saikosaponin D and SP600125 on Lung Cancer A549 Cells.
Chen X; Liu C; Zhao R; Zhao P; Wu J; Zhou N; Ying M
Mol Pharm; 2018 Nov; 15(11):4974-4984. PubMed ID: 30207732
[TBL] [Abstract][Full Text] [Related]
37. TRB3 interacts with ERK and JNK and contributes to the proliferation, apoptosis, and migration of lung adenocarcinoma cells.
Cao X; Fang X; Malik WS; He Y; Li X; Xie M; Sun W; Xu Y; Liu X
J Cell Physiol; 2020 Jan; 235(1):538-547. PubMed ID: 31256425
[TBL] [Abstract][Full Text] [Related]
38. Distinct role of c-Jun N-terminal kinase isoforms in human neutrophil apoptosis regulated by tumor necrosis factor-alpha and granulocyte-macrophage colony-stimulating factor.
Kato T; Noma H; Kitagawa M; Takahashi T; Oshitani N; Kitagawa S
J Interferon Cytokine Res; 2008 Apr; 28(4):235-43. PubMed ID: 18439101
[TBL] [Abstract][Full Text] [Related]
39. SP600125, an inhibitor of Jnk pathway, reduces viability of relatively resistant cancer cells to doxorubicin.
Kim JH; Kim TH; Kang HS; Ro J; Kim HS; Yoon S
Biochem Biophys Res Commun; 2009 Sep; 387(3):450-5. PubMed ID: 19607816
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of basal JNK activity by small interfering RNAs enhances cisplatin sensitivity and decreases DNA repair in T98G glioblastoma cells.
Parra E; Gutiérrez L; Ferreira J
Oncol Rep; 2015 Jan; 33(1):413-8. PubMed ID: 25351964
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
